Search alternatives:
changes increase » change increases (Expand Search), range increase (Expand Search), cases increased (Expand Search)
significant rise » significant risk (Expand Search), significant role (Expand Search), significant cause (Expand Search)
rise decrease » rate decreased (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
changes increase » change increases (Expand Search), range increase (Expand Search), cases increased (Expand Search)
significant rise » significant risk (Expand Search), significant role (Expand Search), significant cause (Expand Search)
rise decrease » rate decreased (Expand Search), sizes decrease (Expand Search), use decreased (Expand Search)
-
81
The mole fraction of arsenic acid (H<sub>3</sub>As(V)O<sub>4</sub>) species as a function of pH.
Published 2024Subjects: -
82
-
83
-
84
-
85
-
86
Acid dissociation data for H<sub>3</sub>As(V)O<sub>4</sub> and H<sub>3</sub>As(III)O<sub>3</sub>.
Published 2024Subjects: -
87
The mole fraction of arsenous acid (H<sub>3</sub>As(III)O<sub>3</sub>) species as a function of pH.
Published 2024Subjects: -
88
-
89
-
90
-
91
-
92
Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth.
Published 2025Subjects: -
93
-
94
-
95
Echocardiogram and morphometrics in pressure-overload hypertrophy (POH) and sham (Sham) groups.
Published 2022Subjects: -
96
Quantification of enzyme activity for CPT1 in experimental groups V-TAC versus TMG-TAC.
Published 2022Subjects: -
97
Global protein O-GlcNAc level in pressure-overload hypertrophy (POH) and sham (Sham) groups.
Published 2022Subjects: -
98
Quantification of enzyme activity for PDH in experimental groups V-TAC versus TMG-TAC.
Published 2022Subjects: -
99
O-GlcNAc immunoprecipitation (IP) for carnitine palmitoyltransferase 1B (CPT1B).
Published 2022Subjects: -
100